AI Automation Workflow for Real-Time Pharmacovigilance and Adverse Event Tracking

Manual pharmacovigilance monitoring is a high-cost, high-latency bottleneck, exposing organizations to compliance risk and delayed signal detection. A custom AI workflow automates the ingestion and triage of adverse event signals from EMRs, literature, and social media, compressing the timeline from detection to validated case. The operational upside comes from reducing manual data entry and review by over 70%, lowering labor costs, and enabling proactive risk management before issues escalate, directly impacting patient safety and regulatory standing.

Implementation integrates with legacy PV systems like Oracle Argus or Veeva Safety via APIs, using a multi-agent architecture for discrete tasks: extraction, MedDRA coding, and causality assessment. Critical controls include configurable confidence thresholds for auto-processing, mandatory medical review gates for serious cases, and comprehensive audit trails for all automated actions. Rollout requires phased ingestion source onboarding, starting with high-volume EMR streams, and parallel validation against manual processes to ensure accuracy before full automation.

This architecture automates the core bottleneck of manual case processing by deploying specialized, collaborative AI agents orchestrated by a central engine like LangGraph. Each agent handles a discrete task—signal ingestion from EMRs and literature, MedDRA coding, causality assessment, or E2B generation—passing state through a managed workflow. The operational upside comes from parallel task execution, 24/7 monitoring, and eliminating handoff delays between legacy systems like ARISg and Veeva Safety, which directly reduces full-time equivalent (FTE) costs and shortens reporting cycles for critical 7- and 15-day deadlines.

Implementation requires integrating this orchestration layer with existing pharmacovigilance databases and clinical data warehouses via secure APIs. Controls are paramount: every agent action is logged, and high-stakes decisions like causality assessment or final report submission are gated by mandatory medical reviewer approval. The rollout is phased, starting with automated triage and coding to build trust before progressing to automated draft generation, ensuring data quality and governance are maintained while delivering measurable reductions in case processing time and labor.

Phase 1 establishes the core ingestion and triage pipeline, targeting the highest-volume, most repetitive bottleneck: processing unstructured adverse event reports from emails, faxes, and web forms. By deploying LLM agents for data extraction and normalization into ICSR fields, this phase alone can cut manual data entry by over 70%, delivering immediate labor savings and data quality improvements. The architecture integrates with existing safety databases like Oracle Argus or Veeva Safety and includes a human-in-the-loop correction queue for validation, ensuring a controlled rollout.

Subsequent phases build on this foundation. Phase 2 adds real-time monitoring of EMR streams and global literature. Phase 3 introduces a LangGraph-orchestrated multi-agent system for automated causality assessment and MedDRA coding. Each phase is designed as a standalone deliverable with its own ROI—faster detection, reduced processing cost, lower compliance risk—while the integrated architecture ensures later phases seamlessly leverage prior investments. Governance, including medical review gates and comprehensive audit trails, is embedded from the start, allowing for controlled scaling of autonomous actions.

Effective governance begins with a centralized control plane, typically implemented via LangGraph, which enforces state transitions, logs all agent decisions, and routes exceptions. This orchestrator integrates with legacy PV systems like Oracle Argus or Veeva Safety, applying business rules for data validation and mandatory medical review gates before any regulatory submission. The architecture must embed explainability layers, capturing the rationale for each triage decision, causality assessment, and MedDRA code suggestion to support audit trails and regulatory inquiries.

Phased rollout mitigates operational risk. Start with a shadow mode where AI agents process signals in parallel with manual workflows, comparing outputs to build confidence. Phase two introduces automation for low-risk, high-volume tasks like literature surveillance and initial case triage, with 100% human review. The final phase automates MedDRA coding and E2B generation, retaining physician sign-off for serious cases. Each phase requires clear KPIs on processing time, false-positive rates, and data quality, with rollback procedures defined in the orchestration layer to maintain compliance during incidents.

This workflow directly targets the operational bottleneck of manual signal monitoring and case processing, which delays regulatory reporting and increases compliance risk. The business value comes from compressing the 15-day reporting clock, reducing manual data entry by over 70%, and enabling proactive risk management. Implementation requires integrating real-time data streams from EMRs (via FHIR/HL7), literature APIs, and call centers into a central orchestration layer, typically built with LangGraph for state management, which coordinates specialized validation and coding agents.

Critical controls include automated quality checks on every case, anomaly detection in audit trails, and mandatory medical review gates before submission. The architecture must integrate with legacy PV systems like Oracle Argus or Veeva Safety and connect to ERP for lot tracking and QMS for quality complaints. Exception handling routes ambiguous signals to human reviewers, while the orchestration layer provides full observability into case status and deadline adherence, creating a defensible, scalable operating model for global safety teams.